Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -290,055 | -176,061 | -88,096 | -21,003 | -83,313 |
| Depreciation Amortization | 11,035 | 10,632 | 9,343 | 9,717 | 10,038 |
| Accounts receivable | 3,358 | 3,677 | 55,194 | -49,057 | -10,849 |
| Accounts payable and accrued liabilities | 4,831 | -1,158 | 7,446 | -1,032 | -3,380 |
| Other Working Capital | 66,258 | -15,501 | 33,480 | 1,953 | -9,680 |
| Other Operating Activity | -229 | 22,821 | -46,452 | 68,411 | 25,669 |
| Operating Cash Flow | $-204,802 | $-155,590 | $-29,085 | $8,989 | $-71,515 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,593 | 105,653 | -104,219 | 85,657 | -159,766 |
| PPE Investments | 1,372 | -7,572 | -16,860 | -5,609 | -4,068 |
| Investing Cash Flow | $41,965 | $98,081 | $-121,079 | $80,048 | $-163,834 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 260,969 | 247,058 | 74,348 | 2,407 | 237,509 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,066 | -2,048 |
| Financing Cash Flow | $260,969 | $247,058 | $74,348 | $1,341 | $235,461 |
| Beginning Cash Position | 286,232 | 96,683 | 172,499 | 82,121 | 61,349 |
| End Cash Position | 384,364 | 286,232 | 96,683 | 172,499 | 61,461 |
| Net Cash Flow | $98,132 | $189,549 | $-75,816 | $90,378 | $112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -204,802 | -155,590 | -29,085 | 8,989 | -71,515 |
| Capital Expenditure | -1,776 | -9,019 | -17,127 | -5,609 | -4,068 |
| Free Cash Flow | -206,578 | -164,609 | -46,212 | 3,380 | -75,583 |